Stock 1H3 CLEARBRIDGE HEALTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Clearbridge Health Limited Stock

Equities

1H3

SG1EB6000000

Healthcare Facilities & Services

Market Closed - Singapore S.E.
Other stock markets
 09:43:08 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.01 SGD 0.00% Intraday chart for Clearbridge Health Limited -9.09% -37.50%
Feb. 29 Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 21 Singapore Shares Fall at Market Close; ValueMax Shares Climb 11% as H2 2023 Profit Surges 44% MT

Financials

Sales 2022 16.41M 12.07M Sales 2023 11.49M 8.45M Capitalization 9.9M 7.29M
Net income 2022 -11M -8.09M Net income 2023 -32M -23.54M EV / Sales 2022 1.49 x
Net Debt 2022 913K 672K Net Debt 2023 2.5M 1.84M EV / Sales 2023 1.08 x
P/E ratio 2022
-2.11 x
P/E ratio 2023
-0.31 x
Employees 121
Yield 2022 *
-
Yield 2023
-
Free-Float 53.03%
More Fundamentals * Assessed data

Chart Clearbridge Health Limited

Dynamic Chart

Latest news about Clearbridge Health Limited

Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Singapore Shares Fall at Market Close; ValueMax Shares Climb 11% as H2 2023 Profit Surges 44% MT
Clearbridge Health Cuts Stake in Singapore Institute of Advanced Medicine; Shares Rise 8% MT
Clearbridge Health's Operations Chief to Step Down by Month-End MT
Clearbridge Health Limited Announces Resignation of Liau Yen San, Jonathan as Chief Operating Officer CI
Clearbridge Health Warns of Lower 2023 Revenue from COVID-19 Test Kits, Medical Services MT
Clearbridge Health Receives Full Amount of Outstanding Debt from Biolidics MT
Clearbridge Health Limited Announces Second Partial Settlement Deed CI
Singapore Stocks End Week in Red; Noel Gifts Zooms 38% as Collective Sale of 50 Playfair Road Singapore Closes MT
Clearbridge Health Unit, Biolidics Sign Deal for Partial Debt Settlement MT
Clearbridge Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Clearbridge Health to Dispose of Over 10% Stake in Biolidics MT
Clearbridge Health Limited Announces Board Changes CI
Clearbridge Health Issues Shares Under Performance Share Plan MT
Clearbridge Health Limited Announces Retirement of Tan Soon Liang (Chen Shunliang) as Independent Director CI
More news

Press releases Clearbridge Health Limited

Labnovation's COVID-19 ART Test Kit, Imported by Clearbridge, is One of the Only Two COVID-19 ART Test Kits in the Philippines Approved by the FDA of the Philippines for Self-Testing AQ
General Announcement::CORPORATE PRESENTATION FOR EGM 2021 PU
General Announcement::PROPOSED EXPANSION OF THE GROUP'S BUSINESS PU
General Announcement::Clearbridge's Second Batch of Sinopharm Vaccine Arrives in Singapore PU
General Announcement::PARTIAL EARLY REDEMPTION AND AMENDEMENT DEED TO TERMS AND CONDITIONS OF CONVERTIBLE BONDS PU
More press releases

Quotes and Performance

1 week-9.09%
Current month-9.09%
3 months-28.57%
6 months-28.57%
Current year-37.50%
More quotes

Highs and lows

1 week
0.01
Extreme 0.01
0.01
1 month
0.01
Extreme 0.01
0.01
Current year
0.01
Extreme 0.009
0.02
1 year
0.01
Extreme 0.009
0.03
3 years
0.01
Extreme 0.009
0.17
5 years
0.01
Extreme 0.009
0.39
10 years
0.01
Extreme 0.009
0.63
More quotes

Managers and Directors - Clearbridge Health Limited

Managers TitleAgeSince
Jeremy Yee CEO
 Chief Executive Officer 54 17-05-14
Wei Chee Tan AUD
 Comptroller/Controller/Auditor 39 22-09-30
Hui Yee Cheok SEC
 Corporate Secretary - 22-06-23
Members of the board TitleAgeSince
Jeremy Yee CEO
 Chief Executive Officer 54 17-05-14
Mark Ryan BRD
 Director/Board Member 57 17-11-19
Andrew Lord BRD
 Director/Board Member 65 17-11-19
More insiders

Quotes

Date Price Change Volume
24-04-24 0.01 0.00% 550 100
24-04-24 0.01 0.00% 65,000
24-04-23 0.01 0.00% 30,000
24-04-22 0.01 0.00% 460,000
24-04-19 0.01 -9.09% 1,220,100

Delayed Quote Singapore S.E., April 24, 2024 at 09:43 pm EDT

More quotes

Company Profile

Clearbridge Health Limited is a Singapore-based investment holding company. The Company is an integrated healthcare group with primary healthcare and healthcare systems. Its segments include healthcare systems, medical clinics/centers, and strategic medical technology investments. The Company’s healthcare system service delivery, health workforce, health information systems, access to essential medicines, and financing. The medical services include general medical services and specialist services. The general medical services include general health services, imaging services, and vaccinations. The specialist services include aesthetics services and dental and orthodontics services. The Company’s strategic medical technology investments include Biolidics Limited (Biolidics) which owns advanced fully automated circulating tumor cell enrichment technology and is developing complete liquid biopsies solutions for clinical use.
Sector
Healthcare Facilities & Services
Calendar
2024-04-28 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CLEARBRIDGE HEALTH LIMITED Stock Clearbridge Health Limited
-37.50% 4.55M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.17% 85.42B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.86% 84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.39B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-8.51% 17.49B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-2.24% 16.44B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.24% 15.28B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.51% 11.71B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+1.05% 12.22B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.40% 11.98B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 1H3 Stock